Global Dihydroartemisinin Sales Market Report 2021

1 Dihydroartemisinin Market Overview

• 1.1 Dihydroartemisinin Product Scope
• 1.2 Dihydroartemisinin Segment by Type
  • 1.2.1 Global Dihydroartemisinin Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Pharmaceutical Grade
  • 1.2.3 Industrial Grade
• 1.3 Dihydroartemisinin Segment by Application
  • 1.3.1 Global Dihydroartemisinin Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Malaria Treatment
  • 1.3.3 Scientific Research
  • 1.3.4 Others
• 1.4 Dihydroartemisinin Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Dihydroartemisinin Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Dihydroartemisinin Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Dihydroartemisinin Price Trends (2016-2027)

2 Dihydroartemisinin Estimates and Forecasts by Region

• 2.1 Global Dihydroartemisinin Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Dihydroartemisinin Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Dihydroartemisinin Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Dihydroartemisinin Revenue Market Share by Region (2016-2021)
• 2.3 Global Dihydroartemisinin Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Dihydroartemisinin Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Dihydroartemisinin Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Dihydroartemisinin Estimates and Projections (2016-2027)
  • 2.4.2 Europe Dihydroartemisinin Estimates and Projections (2016-2027)
  • 2.4.3 China Dihydroartemisinin Estimates and Projections (2016-2027)
  • 2.4.4 Japan Dihydroartemisinin Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Dihydroartemisinin Estimates and Projections (2016-2027)
  • 2.4.6 India Dihydroartemisinin Estimates and Projections (2016-2027)

3 Global Dihydroartemisinin Competition Landscape by Players

• 3.1 Global Top Dihydroartemisinin Players by Sales (2016-2021)
• 3.2 Global Top Dihydroartemisinin Players by Revenue (2016-2021)
• 3.3 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dihydroartemisinin as of 2020)
• 3.4 Global Dihydroartemisinin Average Price by Company (2016-2021)
• 3.5 Manufacturers Dihydroartemisinin Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Dihydroartemisinin Market Size by Type

• 4.1 Global Dihydroartemisinin Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Dihydroartemisinin Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Dihydroartemisinin Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Dihydroartemisinin Price by Type (2016-2021)
• 4.2 Global Dihydroartemisinin Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Dihydroartemisinin Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Dihydroartemisinin Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Dihydroartemisinin Price Forecast by Type (2022-2027)

5 Global Dihydroartemisinin Market Size by Application

• 5.1 Global Dihydroartemisinin Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Dihydroartemisinin Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Dihydroartemisinin Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Dihydroartemisinin Price by Application (2016-2021)
• 5.2 Global Dihydroartemisinin Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Dihydroartemisinin Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Dihydroartemisinin Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Dihydroartemisinin Price Forecast by Application (2022-2027)

6 North America Dihydroartemisinin Market Facts & Figures

• 6.1 North America Dihydroartemisinin Sales by Company
  • 6.1.1 North America Dihydroartemisinin Sales by Company (2016-2021)
  • 6.1.2 North America Dihydroartemisinin Revenue by Company (2016-2021)
• 6.2 North America Dihydroartemisinin Sales Breakdown by Type
  • 6.2.1 North America Dihydroartemisinin Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Dihydroartemisinin Sales Breakdown by Type (2022-2027)
• 6.3 North America Dihydroartemisinin Sales Breakdown by Application
  • 6.3.1 North America Dihydroartemisinin Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Dihydroartemisinin Sales Breakdown by Application (2022-2027)

7 Europe Dihydroartemisinin Market Facts & Figures

• 7.1 Europe Dihydroartemisinin Sales by Company
  • 7.1.1 Europe Dihydroartemisinin Sales by Company (2016-2021)
  • 7.1.2 Europe Dihydroartemisinin Revenue by Company (2016-2021)
• 7.2 Europe Dihydroartemisinin Sales Breakdown by Type
  • 7.2.1 Europe Dihydroartemisinin Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Dihydroartemisinin Sales Breakdown by Type (2022-2027)
• 7.3 Europe Dihydroartemisinin Sales Breakdown by Application
  • 7.3.1 Europe 117 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 117 Sales Breakdown by Application (2022-2027)

8 China Dihydroartemisinin Market Facts & Figures

• 8.1 China Dihydroartemisinin Sales by Company
  • 8.1.1 China Dihydroartemisinin Sales by Company (2016-2021)
  • 8.1.2 China Dihydroartemisinin Revenue by Company (2016-2021)
• 8.2 China Dihydroartemisinin Sales Breakdown by Type
  • 8.2.1 China Dihydroartemisinin Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Dihydroartemisinin Sales Breakdown by Type (2022-2027)
• 8.3 China Dihydroartemisinin Sales Breakdown by Application
  • 8.3.1 China 144 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 144 Sales Breakdown by Application (2022-2027)

9 Japan Dihydroartemisinin Market Facts & Figures

• 9.1 Japan Dihydroartemisinin Sales by Company
  • 9.1.1 Japan Dihydroartemisinin Sales by Company (2016-2021)
  • 9.1.2 Japan Dihydroartemisinin Revenue by Company (2016-2021)
• 9.2 Japan Dihydroartemisinin Sales Breakdown by Type
  • 9.2.1 Japan Dihydroartemisinin Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Dihydroartemisinin Sales Breakdown by Type (2022-2027)
• 9.3 Japan Dihydroartemisinin Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Dihydroartemisinin Market Facts & Figures

• 10.1 Southeast Asia Dihydroartemisinin Sales by Company
  • 10.1.1 Southeast Asia Dihydroartemisinin Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Dihydroartemisinin Revenue by Company (2016-2021)
• 10.2 Southeast Asia Dihydroartemisinin Sales Breakdown by Type
  • 10.2.1 Southeast Asia Dihydroartemisinin Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Dihydroartemisinin Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Dihydroartemisinin Sales Breakdown by Application
  • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Dihydroartemisinin Market Facts & Figures

• 11.1 India Dihydroartemisinin Sales by Company
  • 11.1.1 India Dihydroartemisinin Sales by Company (2016-2021)
  • 11.1.2 India Dihydroartemisinin Revenue by Company (2016-2021)
• 11.2 India Dihydroartemisinin Sales Breakdown by Type
  • 11.2.1 India Dihydroartemisinin Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Dihydroartemisinin Sales Breakdown by Type (2022-2027)
• 11.3 India Dihydroartemisinin Sales Breakdown by Application
  • 11.3.1 India Dihydroartemisinin Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Dihydroartemisinin Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Dihydroartemisinin Business

• 12.1 Sanofi
  • 12.1.1 Sanofi Corporation Information
  • 12.1.2 Sanofi Business Overview
  • 12.1.3 Sanofi Dihydroartemisinin Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Sanofi Dihydroartemisinin Products Offered
  • 12.1.5 Sanofi Recent Development
• 12.2 KPC Pharmaceuticals
  • 12.2.1 KPC Pharmaceuticals Corporation Information
  • 12.2.2 KPC Pharmaceuticals Business Overview
  • 12.2.3 KPC Pharmaceuticals Dihydroartemisinin Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 KPC Pharmaceuticals Dihydroartemisinin Products Offered
  • 12.2.5 KPC Pharmaceuticals Recent Development
• 12.3 Guangxi Xiancaotang Pharmaceutical
  • 12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
  • 12.3.2 Guangxi Xiancaotang Pharmaceutical Business Overview
  • 12.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products Offered
  • 12.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
• 12.4 Guilin Pharmaceutical
  • 12.4.1 Guilin Pharmaceutical Corporation Information
  • 12.4.2 Guilin Pharmaceutical Business Overview
  • 12.4.3 Guilin Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Guilin Pharmaceutical Dihydroartemisinin Products Offered
  • 12.4.5 Guilin Pharmaceutical Recent Development
• 12.5 Kerui Nanhai Pharmaceutical
  • 12.5.1 Kerui Nanhai Pharmaceutical Corporation Information
  • 12.5.2 Kerui Nanhai Pharmaceutical Business Overview
  • 12.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products Offered
  • 12.5.5 Kerui Nanhai Pharmaceutical Recent Development
• 12.6 Shanghai Natural Bio-engineering Co
  • 12.6.1 Shanghai Natural Bio-engineering Co Corporation Information
  • 12.6.2 Shanghai Natural Bio-engineering Co Business Overview
  • 12.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products Offered
  • 12.6.5 Shanghai Natural Bio-engineering Co Recent Development
• 12.7 Novanat Bioresource
  • 12.7.1 Novanat Bioresource Corporation Information
  • 12.7.2 Novanat Bioresource Business Overview
  • 12.7.3 Novanat Bioresource Dihydroartemisinin Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Novanat Bioresource Dihydroartemisinin Products Offered
  • 12.7.5 Novanat Bioresource Recent Development
• 12.8 Botanical Extracts EPZ Ltd
  • 12.8.1 Botanical Extracts EPZ Ltd Corporation Information
  • 12.8.2 Botanical Extracts EPZ Ltd Business Overview
  • 12.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products Offered
  • 12.8.5 Botanical Extracts EPZ Ltd Recent Development

13 Dihydroartemisinin Manufacturing Cost Analysis

• 13.1 Dihydroartemisinin Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Dihydroartemisinin
• 13.4 Dihydroartemisinin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Dihydroartemisinin Distributors List
• 14.3 Dihydroartemisinin Customers

15 Market Dynamics

• 15.1 Dihydroartemisinin Market Trends
• 15.2 Dihydroartemisinin Drivers
• 15.3 Dihydroartemisinin Market Challenges
• 15.4 Dihydroartemisinin Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List